NCT02043795View on ClinicalTrials.gov

Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study)

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2013

Primary Completion Date

March 19, 2018

Study Completion Date

February 28, 2019

Conditions
Critical Limb Ischemia
Interventions
DEVICE

BVS, Abbott Vascular

The aim of this study is to study the safety and clinical efficacy of a novel Bioabsorbable Everolimus Eluting Bioresorbable Vascular Scaffold System (BVS, Abbott Vascular).

Trial Locations (1)

529889

Changi General Hospital, Singapore

All Listed Sponsors
lead

Changi General Hospital

OTHER

NCT02043795 - Drug Impregnated Bioabsorbable Stent in Asian Population Extremity Arterial Revascularization (DISAPEAR Study) | Biotech Hunter | Biotech Hunter